216 results on '"Picco, Agnese"'
Search Results
2. Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease
3. Neuroimaging Findings in Mild Cognitive Impairment
4. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
5. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study
6. Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
7. Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
8. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
9. Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG in the differential diagnosis between Alzheimer's disease and dementia with Lewy bodies in the context of a structured 5-phase development framework
10. Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data
11. Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson’s disease and probable RBD
12. Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: A multicentric resting-state fMRI study
13. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
14. Early identification of MCI converting to AD: a FDG PET study
15. 18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage
16. Neuroimaging Findings in Mild Cognitive Impairment
17. Multisite longitudinal reliability of tract-based spatial statistics in diffusion tensor imaging of healthy elderly subjects
18. Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD
19. Parkinson’s Disease Sleep Scale 2: application in an Italian population
20. Prediction of cognitive worsening in de novo Parkinsonʼs disease: Clinical use of biomarkers
21. Brain 18F-DOPA PET and cognition in de novo Parkinson’s disease
22. Correlation between Doppler Velocities and Duplex Ultrasound Carotid Cross-sectional Percent Stenosis
23. Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints
24. Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques
25. Longitudinal reproducibility of automatically segmented hippocampal subfields: A multisite European 3T study on healthy elderly
26. Resting metabolic connectivity in Alzheimer’s disease
27. Biomarkers validation in Alzheimer’s Disease and related pathologies
28. Accuracy and reproducibility of automated white matter hyperintensities segmentation with lesion segmentation tool: A European multi-site 3T study
29. Una sfida per la scienza: Genesi ed evoluzione del pensiero di Cesare Lombroso sullo spiritismo.
30. White Matter Hyperintensities Are No Major Confounder for Alzheimer’s Disease Cerebrospinal Fluid Biomarkers
31. Amygdalar nuclei and hippocampal subfields on MRI: Test‐retest reliability of automated segmentation in old and young healthy volunteers
32. Amygdalar nuclei and hippocampal subfields on MRI: Test-retest reliability of automated volumetry across different MRI sites and vendors
33. What predicts cognitive decline in de novo Parkinson's disease?
34. Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease
35. IC‐P‐006: THE INCREMENTAL VALUE OF AMYLOID PET VERSUS CSF BIOMARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (INDIA–FBB STUDY)
36. P1‐393: THE INCREMENTAL VALUE OF AMYLOID PET VERSUS CSF BIOMARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (INDIA–FBB STUDY)
37. IC‐P‐126: VOLUMETRIC ACCURACY OF A FULLY AUTOMATIC TOOL FOR WHITE MATTER HYPERINTENSITIES (WMHS) SEGMENTATION
38. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study
39. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
40. [IC-P-167]: ACROSS-SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI-SITE 3T STUDY
41. ACROSS-SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI-SITE 3T STUDY
42. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
43. IC‐P‐006: THE INCREMENTAL VALUE OF AMYLOID PET VERSUS CSF BIOMARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (INDIA–FBB STUDY).
44. Free water elimination improves test–retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects
45. Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer’s Disease Patients and Controls after Correction for Ventricular Volumes
46. P3-209: Impact of Biomarkers On Diagnostic Confidence in Clinical Assessment of Patients with Suspected Alzheimer's Disease and High Diagnostic Uncertainty: An EADC Study
47. P4‐190: 18FDG PET Predicts Time to Disease Milestones in a Naturalistic Population of Mild Cognitive Impairment (MCI) Due to Alzheimer’s Disease
48. Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis?
49. Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC)
50. Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.